Literature DB >> 23596257

Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.

Antonio Bertoletti1, Carlo Ferrari.   

Abstract

Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has accelerated in recent years, but their translation towards therapeutic strategies able to achieve a durable HBV suppression has been challenging. The scenario of how HBV deals with the host immunity is presented and used to discuss how the immune response can be harnessed to potentially achieve infection control.

Entities:  

Year:  2013        PMID： 23596257     DOI： 10.1136/postgradmedj-2011-301073rep

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  23 in total

1.  Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model.

Authors:  I-Tsu Chyuan; Hwei-Fang Tsai; Horng-Tay Tzeng; Chi-Chang Sung; Chien-Sheng Wu; Pei-Jer Chen; Ping-Ning Hsu
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

Review 2.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

Review 3.  Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

Authors:  Francesca De Nard; Monica Todoerti; Vittorio Grosso; Sara Monti; Silvia Breda; Silvia Rossi; Carlomaurizio Montecucco; Roberto Caporali
Journal:  World J Hepatol       Date:  2015-03-27

Review 4.  Treatment of hepatitis B virus: an update.

Authors:  Haley Ward; Lydia Tang; Bhawna Poonia; Shyam Kottilil
Journal:  Future Microbiol       Date:  2016-11-18       Impact factor: 3.165

5.  Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B.

Authors:  Erdem Akbal; Erdem Koçak; Seyfettin Köklü; Bilal Ergül; Ömer Akyürek; Fatma Meriç Yılmaz
Journal:  Viral Immunol       Date:  2017-04-17       Impact factor: 2.257

Review 6.  Eradication Strategies for Chronic Hepatitis B Infection.

Authors:  Eleanor M P Wilson; Lydia Tang; Shyam Kottilil
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

Review 7.  Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

Authors:  Li Wang; Kai Wang; Zhi-Qiang Zou
Journal:  World J Hepatol       Date:  2015-12-28

8.  Altered mRNA levels of MOV10, A3G, and IFN-α in patients with chronic hepatitis B.

Authors:  Zhi-Wei Song; Yan-Xiu Ma; Bao-qing Fu; Xu Teng; Si-Jia Chen; Wei-Zhen Xu; Hong-Xi Gu
Journal:  J Microbiol       Date:  2014-05-29       Impact factor: 3.422

9.  Strategies to eliminate HBV infection.

Authors:  Rama Kapoor; Shyam Kottilil
Journal:  Future Virol       Date:  2014       Impact factor: 1.831

10.  HBeAg induces the expression of macrophage miR-155 to accelerate liver injury via promoting production of inflammatory cytokines.

Authors:  Wenwen Wang; Hongjun Bian; Feifei Li; Xiao Li; Di Zhang; Shuohuan Sun; Shouyang Song; Qiang Zhu; Wanhua Ren; Chengyong Qin; Jianni Qi
Journal:  Cell Mol Life Sci       Date:  2018-01-18       Impact factor: 9.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.